View in EDS

Dramatic Improvement of Antitranscription Intermediary Factor-1-γ/α Antibody-Positive Dermatomyositis After Stereotactic Body Radiation Therapy to Presumed Lung Primary: A Case Report.

Saved in:
Bibliographic Details
Title: Dramatic Improvement of Antitranscription Intermediary Factor-1-γ/α Antibody-Positive Dermatomyositis After Stereotactic Body Radiation Therapy to Presumed Lung Primary: A Case Report.
Authors: Kuczmarska-Haas A; Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin., Burr AR; Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin., Witt JS; Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin., Francis DM; Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin., Ali H; Department of Dermatology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin., Sonneborn H; Radiation Oncology Associates Seacoast Cancer Center, Dover, New Hampshire., Mahadevan A; Radiation Oncology Associates Seacoast Cancer Center, Dover, New Hampshire., Brower JV; Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin; Radiation Oncology Associates Seacoast Cancer Center, Dover, New Hampshire. Electronic address: jvbrower@wisc.edu.
Source: Practical radiation oncology [Pract Radiat Oncol] 2020 Nov - Dec; Vol. 10 (6), pp. e551-e556. Date of Electronic Publication: 2020 Jul 02.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101558279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-8519 (Electronic) Linking ISSN: 18798500 NLM ISO Abbreviation: Pract Radiat Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-8519
DOI:10.1016/j.prro.2020.06.008